Open Access
Open access
volume 17 issue 9 pages 1241

Facile Synthesis of N-(4-Bromo-3-methylphenyl)pyrazine-2-carboxamide Derivatives, Their Antibacterial Activities against Clinically Isolated XDR S. Typhi, Alkaline Phosphatase Inhibitor Activities, and Docking Studies

Publication typeJournal Article
Publication date2024-09-20
scimago Q1
wos Q1
SJR1.019
CiteScore7.7
Impact factor4.8
ISSN14248247
PubMed ID:  39338403
Abstract

The emergence of extensively drug-resistant Salmonella Typhi (XDR-S. Typhi) poses a grave public health threat due to its resistance to fluoroquinolones and third-generation cephalosporins. This resistance significantly complicates treatment options, underscoring the urgent need for new therapeutic strategies. In this study, we synthesized pyrazine carboxamides (3, 5a–5d) in good yields through the Suzuki reaction. Afterward, we evaluate their antibacterial activities against XDR-S. Typhi via the agar well diffusion method; 5d has the strongest antibacterial activity with MIC 6.25 (mg/mL). Moreover, in vitro Alkaline Phosphatase inhibitor activity was also determined; 5d is the most potent compound, with an IC50 of 1.469 ± 0.02 µM. Further, in silico studies were performed to find the type of interactions between synthesized compounds and target proteins.

Found 
Found 

Top-30

Journals

1
Journal of Computational Biophysics and Chemistry
1 publication, 25%
Chemistry and Biodiversity
1 publication, 25%
Journal of Water Process Engineering
1 publication, 25%
ChemistrySelect
1 publication, 25%
1

Publishers

1
2
Wiley
2 publications, 50%
World Scientific
1 publication, 25%
Elsevier
1 publication, 25%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
4
Share
Cite this
GOST |
Cite this
GOST Copy
Khan A. H. et al. Facile Synthesis of N-(4-Bromo-3-methylphenyl)pyrazine-2-carboxamide Derivatives, Their Antibacterial Activities against Clinically Isolated XDR S. Typhi, Alkaline Phosphatase Inhibitor Activities, and Docking Studies // Pharmaceuticals. 2024. Vol. 17. No. 9. p. 1241.
GOST all authors (up to 50) Copy
Khan A. H., Bilal M., Mahmood A., Rasool N., Qamar M. U., Imran M., Toma S. I., Andreescu O. Facile Synthesis of N-(4-Bromo-3-methylphenyl)pyrazine-2-carboxamide Derivatives, Their Antibacterial Activities against Clinically Isolated XDR S. Typhi, Alkaline Phosphatase Inhibitor Activities, and Docking Studies // Pharmaceuticals. 2024. Vol. 17. No. 9. p. 1241.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/ph17091241
UR - https://www.mdpi.com/1424-8247/17/9/1241
TI - Facile Synthesis of N-(4-Bromo-3-methylphenyl)pyrazine-2-carboxamide Derivatives, Their Antibacterial Activities against Clinically Isolated XDR S. Typhi, Alkaline Phosphatase Inhibitor Activities, and Docking Studies
T2 - Pharmaceuticals
AU - Khan, Abdul Hannan
AU - Bilal, Muhammad
AU - Mahmood, Abid
AU - Rasool, Nasir
AU - Qamar, Muhammad Usman
AU - Imran, Muhammad
AU - Toma, Sebastian Ionut
AU - Andreescu, Oana
PY - 2024
DA - 2024/09/20
PB - MDPI
SP - 1241
IS - 9
VL - 17
PMID - 39338403
SN - 1424-8247
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Khan,
author = {Abdul Hannan Khan and Muhammad Bilal and Abid Mahmood and Nasir Rasool and Muhammad Usman Qamar and Muhammad Imran and Sebastian Ionut Toma and Oana Andreescu},
title = {Facile Synthesis of N-(4-Bromo-3-methylphenyl)pyrazine-2-carboxamide Derivatives, Their Antibacterial Activities against Clinically Isolated XDR S. Typhi, Alkaline Phosphatase Inhibitor Activities, and Docking Studies},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
publisher = {MDPI},
month = {sep},
url = {https://www.mdpi.com/1424-8247/17/9/1241},
number = {9},
pages = {1241},
doi = {10.3390/ph17091241}
}
MLA
Cite this
MLA Copy
Khan, Abdul Hannan, et al. “Facile Synthesis of N-(4-Bromo-3-methylphenyl)pyrazine-2-carboxamide Derivatives, Their Antibacterial Activities against Clinically Isolated XDR S. Typhi, Alkaline Phosphatase Inhibitor Activities, and Docking Studies.” Pharmaceuticals, vol. 17, no. 9, Sep. 2024, p. 1241. https://www.mdpi.com/1424-8247/17/9/1241.